Motivation: CNValidator assesses the quality of somatic copy-number calls based on coherency of haplotypes across multiple samples from the same individual. It is applicable to any copy-number calling algorithm, which makes calls independently for each sample. This test is useful in assessing the accuracy of copy-number calls, as well as choosing among alternative copy-number algorithms or tuning parameter values. Results: On a dataset of somatic samples from individuals with Barrett's Esophagus, CNValidator provided feedback on the correctness of sample ploidy calls and also detected data quality issues.
Introduction
Studies of somatic variation within organisms, particularly in neoplasia and cancers, often require inference of somatic changes in copy number. Such inference can be based on SNP array data using programs such as ASCAT (Van Loo et al., 2010) or ABSOLUTE (Carter et al., 2012) , or on sequencing data using programs such as ascatNgs (Raine et al., 2016) . If copy-number inference is inaccurate, downstream conclusions may be incorrect.
We present the haplotype coherency test, which leverages information from multiple samples from the same patient to estimate the accuracy of inferred allele-specific copy-number calls. This test assumes that cross-sample haplotype coherency was not considered in the calls, which is true for most copy-number calling algorithms.
The test is illustrated in Figure 1 . An individual's germline is assumed to have two haplotypes (A and B) distinguished by the alleles present at heterozygous sites. We assume that as part of copynumber calling, the genome has been divided into segments of presumed constant copy number, and each segment has been assigned counts of the A and B haplotypes.
If a somatic event has generated a segment with more copies of one haplotype than the other (such as a single-copy gain or loss) we will term it 'unbalanced'. An unbalanced region identifies which alleles are present on each haplotype: the allele frequencies of alleles on the more frequent haplotype will be shifted upwards, and those on the less frequent haplotype will be shifted downward. In contrast, in a 'balanced' segment (equal numbers of A and B haplotypes, such as a normal diploid), the pattern of allele frequencies will be due to noise and will not reflect the underlying haplotypes.
Thus, we expect that if a calling algorithm assigns an unbalanced call to a segment, the haplotypes indicated by the pattern of allele frequencies should match those in other samples where the segment is also unbalanced. If the haplotypes do not match, the call is likely wrong. Conversely, if a calling algorithm assigns a balanced call, the haplotypes should not match those in other samples. If the haplotypes do match, the call is likely wrong. Only the balanced/unbalanced status of the call is verified, not the exact call made: a miscall such as 2A/2B for 1A/1B cannot be detected.
The test is implemented by identifying heterozygous positions in the germline using a control sample. Only segments which span at least 10 germline heterozygous positions can be used. Each position is then scored as being above or below 0.5 in each somatic sample. For each segment, two samples are considered to agree on the underlying haplotypes when 95% or more of their heterozygous positions 
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CNValidator requires B-allele frequencies from array or sequencing data (though we have practical experience only with array data), and segments and copy-number calls from a copy-number algorithm. It uses simple input formats which can be easily prepared from a variety of file formats. It produces overall reports on the accuracy of each sample, and detailed reports covering each segment. It can be run either to validate a single copy-number algorithm, or to compare two or more algorithms or sets of algorithm parameters; in the latter case, it evaluates the union of segments called by all of the tested algorithms. It is written in Python 2 and is available under the MIT License.
Application
We developed this algorithm to validate calling on a mixture of Illumina 1.0 and 2.5 M SNP array data for 3-30 samples per individual from 210 individuals with Barrett's Esophagus (BE) from the Seattle BE Study (Li et al., 2014 and additional unpublished data) . We performed segmentation with a customized version of copynumber (Nilsen et al., 2012) and copy-number calling with a customized version of ASCAT (Martinez et al., 2018; Van Loo et al., 2010 ) (see Supplementary Material). For each sample, ASCAT was used to find the best ploidy estimate below 2.80 ('low-ploidy') and the best estimate 2.80 and above ('high-ploidy'). Our goals were to validate copy-number calling overall and also to determine which ploidy baseline was preferable for each sample. We report only on the 1654 samples for which ASCAT found solutions for both baselines and at least one segment was validatable, and omit eight patients who either lacked solutions in either category, or had no validatable segments due to lack of copy-number variation.
For most samples (932/1654) both baselines had accuracy over 90%, reflecting the difficulty of distinguishing a cleanly genomedoubled sample from a diploid one (Supplementary Fig. S1 ). However, for 402 samples one solution was clearly preferable (260 low-and 142 high-ploidy). For example, sample 1005-24 100 had a low-ploidy accuracy of 33% and high-ploidy of 96%. Examination of individual calls showed many segments with inferred fractional copy number that would round to a balanced call with a low-ploidy baseline, but to an unbalanced call with a high-ploidy baseline; the coherency test strongly favored the unbalanced calls and thus the assignment of a high-ploidy baseline for this sample.
Accuracy was below 90% for both baselines for 320 samples. This may indicate high subclonality or noisy data. One striking case was patient 572. External evidence suggested high-ploidy solutions, but the inferred accuracy of these solutions was low (33-93%, see Supplementary Table S1 ). Quality control checks showed that this patient had been run using the wrong normal control; when the analysis was repeated with the correct control, accuracies were over 98%.
Discussion
Our BE results show the usefulness of CNValidator both in choosing among alternative copy-number approaches (in our case, low-versus high-ploidy baseline) and in detecting failure of copy-number calling, in our case due to a quality-control issue.
The approach used by CNValidator applies only to multiple samples from the same individual. In principle population-based haplotype inference could be used to validate single samples as is done by the Battenberg algorithm (Nik-Zainal et al., 2012) , although this would be vulnerable to errors in the inferred haplotypes. CNValidator requires at least two somatic samples but is more powerful with more samples (see Supplementary Fig. S3 ). Regions of subclonal copy-number variation can cause disagreement between the calling algorithm and CNValidator; CNValidator will sometimes detect unbalanced states from subclones that are not present in the majority clone. More work is required to assess the performance of CNValidator in the face of subclonality. Finally, CNValidator relies on the segmentation it is given; a separate approach will be needed to detect segmentation failures.
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